The indolent and aggressive behaviors of HCC might have a role in clinical trial (CT) results;
however, the indolent HCC is less analyzed compared to others cancer. Indolent profile …

Results: Recent therapeutic advances observed in the management of HCC, notably
through the advent of immunotherapy, have led to a clear improvement in the survival of …

The treatment decisions for patients with hepatocellular carcinoma are determined by a wide
range of factors, and there is a significant difference between the recommendations of …

Background and Aims Autoimmune hepatitis (AIH) is a rare chronic liver disease of unknown
aetiology; the risk of hepatocellular carcinoma (HCC) remains unclear and risk factors are …

Alcohol-associated liver disease (ALD) is the most common cause of advanced hepatic
disease and frequent indication for liver transplantation worldwide. With harmful alcohol use …

PURPOSE There are limited data on antiviral treatment utilization and its impact on long-
term outcomes of hepatitis B virus (HBV)–and hepatitis C virus (HCV)–related hepatocellular …

Despite that surgical resection is widely regarded as the most effective approach to the
treatment of liver cancer, its safety and efficacy upon centrally located hepatocellular …

Hepatocellular carcinoma (HCC) presents significant treatment challenges despite
considerable advancements in its management. The Indian National Association for the …

Immunotherapies such as immune checkpoint blockade have achieved remarkable success
in treating cancer. Unfortunately, response rates have been limited in multiple cancers …

Background & Aims Sex-related differences in the immune pathogenesis of hepatocellular
carcinoma (HCC), particularly related to oestrogen-dependent secretion of pro-tumourigenic …